Bendrofumethiazide en es it fr

Bendrofumethiazide Brand names, Bendrofumethiazide Analogs

Bendrofumethiazide Brand Names Mixture

  • Corzide Tab W Nadolol 40mg (Bendroflumethiazide + Nadolol)
  • Corzide Tab W Nadolol 80mg (Bendroflumethiazide + Nadolol)

Bendrofumethiazide Chemical_Formula

C15H14F3N3O4S2

Bendrofumethiazide RX_link

No information avaliable

Bendrofumethiazide fda sheet

Bendrofumethiazide msds (material safety sheet)

Bendrofumethiazide Synthesis Reference

No information avaliable

Bendrofumethiazide Molecular Weight

421.417 g/mol

Bendrofumethiazide Melting Point

221-223 oC

Bendrofumethiazide H2O Solubility

108 mg/L

Bendrofumethiazide State

Solid

Bendrofumethiazide LogP

2.085

Bendrofumethiazide Dosage Forms

Tablet

Bendrofumethiazide Indication

For the treatment of high blood pressure and management of edema

Bendrofumethiazide Pharmacology

Bendroflumethiazide, a thiazide diuretic, removes excess water from the body by increasing how often you urinate (pass water) and also widens the blood vessels which helps to reduce blood pressure. It inhibits Na+/Cl- reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue.

Bendrofumethiazide Absorption

Absorbed relatively rapidly after oral administration

Bendrofumethiazide side effects and Toxicity

No information avaliable

Bendrofumethiazide Patient Information

No information avaliable

Bendrofumethiazide Organisms Affected

Humans and other mammals